The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 13th 2025
Administration during peak vaccine effectiveness provides maximal protective benefit
NIH to Assess, Expand COVID-19 Testing for Underserved Communities
September 30th 2020The announcement is part of the Rapid Acceleration of Diagnostics (RADx) initiative and the RADx Underserved Populations (RADx-UP) program, which will support 32 institutions across the United States and focus on populations disproportionately affected by the pandemic.
Read More
Adapting Operations to Meet the Needs of the Community
September 30th 2020Pharmacy Times® interviewed Brian Nightengale, RPh, PhD, president of Good Neighbor Pharmacy, on the value of diversifying a pharmacy’s business to meet the needs of the customer and adapt to the immediate needs of the community, such as during the COVID-19 pandemic.
Watch
Study: Having Pets Linked to Better Mental Health, Reduced Loneliness During COVID-19 Lockdown
September 29th 2020Survey shows that having a pet was linked to maintaining better mental health and reduced loneliness, with 90% of the 6000 participants from the UK saying they had at least 1 pet.
Read More
Monday Pharmaceutical Mystery: What Caused Health-conscious People to Get Incredibly Sick in 1989?
September 28th 2020In 1989, more than 1500 young, healthy people started experiencing mysterious symptoms that included unusual skin rashes, muscle pains, dramatic eosinophilia, and tightening of the skin.
Read More
Study Shows Tethering Together Type 2 Diabetes Drugs Increases Efficacy of Combination Therapy
September 25th 2020Researchers at Duke University have found that the efficacy of a 2-pronged type 2 diabetes (T2D) treatment increases when the drugs are linked by a heat-sensitive tether rather than simply being concurrently administered, according to a press release.
Read More
Study: Certain Immunosuppressing Drugs Do Not Increase Risk for Contracting COVID-19
September 23rd 2020A recent study found that patients on immunosuppressive therapy for common skin and rheumatic diseases, such as psoriasis and rheumatoid arthritis, are not at an increased risk for contracting COVID-19.
Read More